Delhi HC Dismisses Novo Nordisk’s Appeal To Block Dr Reddy’s Key Ozempic Ingredient Exports by NDTV Profits | March 9, 2026 4:30 pm | Latest Posts, Market, Trending News This development comes after Novo Nordisk was preparing to unveil its semaglutide based drug ‘Extensior’ in India.
